Test Code KCSFP Immunoglobulin Kappa Free Light Chain, Spinal Fluid (Non-Orderable)
Ordering Guidance
For evaluation of multiple sclerosis, the following are also available as individually orderable tests:
SFIG / Cerebrospinal Fluid IgG Index Profile, Serum and Spinal Fluid
OLIG / Oligoclonal Banding, Serum and Spinal Fluid
Specimen Required
Only orderable as part of a profile. For more information see MSP3 / Multiple Sclerosis (MS) Cascade, Serum and Spinal Fluid.
Specimen Type: Spinal fluid (CSF)
Container/Tube: Sterile vial
Specimen Volume: 1 mL
Collection Instructions:
1. Submit CSF from collection vial number 4 (preferred); vial number 1, 3, and 2 are also acceptable (in this order).
2. Label specimen as CSF.
Useful For
Only orderable as part of a profile. For more information see MSP3 / Multiple Sclerosis (MS) Cascade, Serum and Spinal Fluid.
Diagnosis of multiple sclerosis and other demyelinating conditions
Method Name
Only orderable as part of a profile. For more information see MSP3 / Multiple Sclerosis (MS) Cascade, Serum and Spinal Fluid.
Nephelometry
Reporting Name
Kappa Free Light Chain, CSFSpecimen Type
CSFSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| CSF | Frozen (preferred) | 28 days |
| Refrigerated | 72 hours | |
| Ambient | 24 hours |
Reject Due To
| Gross hemolysis | Reject |
| Gross icterus | OK |
Reference Values
Only orderable as part of a profile. For more information see MSP3 / Multiple Sclerosis (MS) Cascade, Serum and Spinal Fluid.
Medical decision point: 0.1000 mg/dL
Positive: ≥0.1000 mg/dL
Borderline: 0.0600 mg/dL-0.0999 mg/dL
Negative: <0.0600 mg/dL
Interpretation
Cerebrospinal fluid (CSF) kappa free light chain (kFLC) concentration is a quantitative marker of immunoglobulin production within the central nervous system but may also be influenced by circulating kFLC concentration and blood-CSF barrier permeability.
Results are interpreted as:
Negative: <0.0600 mg/dL
Borderline: 0.0600 to <0.1000 mg/dL
Positive: ≥0.1000 mg/dL
An increased CSF kFLC concentration is not specific for multiple sclerosis (MS) and may occur in other inflammatory, infectious, autoimmune, malignant, and neurologic disorders. Clinical and radiologic correlation is recommended.
Standalone CSF kFLC concentration should not be confused with the kFLC index. The kFLC index incorporates paired CSF and serum kFLC and albumin measurements and is the kFLC-based approach recommended for demonstrating positive CSF in the 2024 McDonald criteria.(1)
The 2024 McDonald criteria recognize intrathecal kFLC synthesis as an alternative to CSF-restricted oligoclonal bands for demonstrating a positive CSF result.(1) The recommended approach is calculation of the kFLC index:
kFLC index = (CSF kFLC / serum kFLC) / (CSF albumin / serum albumin)
The calculation requires paired CSF and serum kFLC and albumin measurements. A kFLC index greater than or equal to 6.1 is the recommended threshold for positive CSF when validated assays are used.
Mayo Clinic Laboratories provides the Kappa Index Calculator to facilitate calculation of the index and determine whether the result meets the greater than or equal to 6.1 threshold. A positive kFLC index supports intrathecal immunoglobulin synthesis but is not specific for MS and should be interpreted with clinical and imaging findings.
Day(s) Performed
Monday through Friday
Report Available
1 to 3 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
83521
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| KCSFP | Kappa Free Light Chain, CSF | 48774-4 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| KCSFP | Kappa Free Light Chain, CSF | 48774-4 |